Nuzenio

Buy Rating

Buy Rating news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Analysts Offer Insights on Materials Companies: MP Materials (MP), Galiano Gold (GAU) and Nutrien (NTR) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 19:49:17 GMT New Buy Rating for Cloudflare (NET), the Technology Giant - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 13:32:15 GMT J.P. Morgan Keeps Their Buy Rating on Booking Holdings (BKNG) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 12:20:03 GMT These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Arista Beats Views - Investor's Business DailyInvestor's Business Daily · Sat, 08 Aug 2026 12:00:00 GMT Proto Labs (NYSE:PRLB) Rating Increased to Strong-Buy at Zacks Research - MarketBeatMarketBeat · Sat, 08 Aug 2026 11:52:01 GMT Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Strong-Buy at Zacks Research - MarketBeatMarketBeat · Sat, 08 Aug 2026 11:44:17 GMT People Incorporated Common Stock (NASDAQ:PPLI) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeatMarketBeat · Sat, 08 Aug 2026 11:44:16 GMT Matson (NYSE:MATX) Rating Increased to Strong-Buy at Zacks Research - MarketBeatMarketBeat · Sat, 08 Aug 2026 11:42:01 GMT

Timeline

Sat, 08 Aug 2026 19:49:17 GMTAnalysts Offer Insights on Materials Companies: MP Materials (MP), Galiano Gold (GAU) and Nutrien (NTR) - The Globe and Mail

Sat, 08 Aug 2026 13:32:15 GMTNew Buy Rating for Cloudflare (NET), the Technology Giant - The Globe and Mail

Sat, 08 Aug 2026 12:20:03 GMTJ.P. Morgan Keeps Their Buy Rating on Booking Holdings (BKNG) - The Globe and Mail

Sat, 08 Aug 2026 12:00:00 GMTThese 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Arista Beats Views - Investor's Business Daily

Sat, 08 Aug 2026 11:52:01 GMTProto Labs (NYSE:PRLB) Rating Increased to Strong-Buy at Zacks Research - MarketBeat

Sat, 08 Aug 2026 11:44:17 GMTSupernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Strong-Buy at Zacks Research - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

NYSE26 live mentions Buy22 live mentions Wall Street Zen20 live mentions Rating Increased14 live mentions Strong14 live mentions NASDAQ12 live mentions Upgraded12 live mentions Moderate Buy10 live mentions MarketBeat7 live mentions Rating6 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Buy Rating.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.